About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Azithromycin Reduction to Reach Elimination of Trachoma B

NCT06289647·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of California, San Francisco

With

Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
National Eye Institute (NEI)

Age

0–9

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Provision of appropriate informed consent
Stated willingness to comply with all study procedures
Live in one of the 80 communities with up to 20% prevalence of TF selected for the trial

You may not be if

Does not consent to participation
Unwilling to comply with all study procedures
Does not live in one of the 80 communities with up to 20% prevalence of TF selected for the trial

The record

StatusWithdrawn

PhasePhase 4

Taking part0

StartedOct 2024

UpdatedMar 13, 2026

Conditions

Where1

University of California, San Francisco
Kindu, Maniema Province, Democratic Republic of the Congo

Clareo Health | Azithromycin Reduction to Reach Elimination of Trachoma B